High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden.

Axel G AnderssonAnna LundgrenYiyi XuChristel NielsenChristian H LindhDaniela PinedaJulia CederlundElisavet PataridouSandra Søgaard TøttenborgKajsa Ugelvig PetersenTony FletcherMartin LaggingMats BemarkKristina JakobssonYing Li

Published in: Environmental health perspectives (2023)

Following a strict study protocol, rigorous study design, and few dropouts, we found no indication that PFAS exposure negatively affected antibody responses to COVID-19 mRNA vaccination for up to 6 months after vaccination. https://doi.org/10.1289/EHP11847.

Keyphrases

sars cov
study protocol
respiratory syndrome coronavirus
coronavirus disease
randomized controlled trial
binding protein
clinical trial
drinking water